Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.
FOX 13's Lloyd Sowers reports on the FDA approving OneBlood's High Titer COVID-19 convalescent plasma treatment for immunocompromised patients.